Extended Follow-Up of the Safety of 131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma

New Drugs

October 26, 2010

The copyright for all illustrations and pictures has been heeded by all authors to the best of their knowledge. If you feel your copyright has been infringed in any way or if you have any questions, do contact us by clicking on this link, please.

Further Lectures

BEACOPP, ABVD and High Tumor Burden

Advanced Stages

Intensified ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin’s Lymphoma

Advanced Stages

PET assessment of residual tissue in advanced-stage HL: Final analysis of the HD15-PET trial

Advanced Stages

FDG-PET in the Design of Involved node Radiotherapy

PET

Go to congress

• Infos